# Eikon Therapeutics, Inc.: Form S-1/A, filed Jan 28, 2026

- Company: [Eikon Therapeutics, Inc.](/companies/eikn.md) (CIK 1861123)
- Form: S-1/A
- Filed: 2026-01-28
- Accepted by EDGAR: Jan 28, 2026, 06:03 ET
- Period: not reported
- Accession: 0001193125-26-025565
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1861123/000119312526025565/d903262ds1a.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1861123/000119312526025565/

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1861123/000119312526025565/d903262ds1a.htm

Filed Jan 28, 2026.
Source: SEC EDGAR, the filing index for accession 0001193125-26-025565. Last ingested by Listed: Oct 26, 2026, 06:02 ET. No prices; not investment advice.